Ann: Marketing and Distribution Agreement signed for China, page-11

I was a holder previously, and still on my radar. But sold out prior to consolidation. I think colustrum in general is going to play a bigger role in medicine in the future. It has already become more popular in the veterinary field, and human medicine tends to be a little behind vet medicine. So it should pick up.
But I think the reason the SP hasnt jumped is partly because it will take some time for sales in China to start, and then catch on, and also IMC may not be on peoples radars.
I will likely buy in again in the coming weeks, once I free up some money.

For those who are unfamiliar with colustrum, just read online about it in vet forums. There are a lot of applications for it, and is much better than antibiotics and seems much healthier.